Susan Hasty, Publisher
Table of Contents . . . January 12th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Hepatitis C Therapy - Consolidation therapy improves sustained response in HCV genotype 1b patients
Cirrhosis - TIPS improves cardiac function in hypovolemic patients
Collaborations - Nonexclusive HCV license granted to Boehringer Ingelheim
Finance - Drug discovery company announces 2003 net loss of $3,925,000
Finance - Gene identification company reports 73.7% gross profit margin
Gastroenterology - TNF-alpha may play an early role in the malignant transformation of liver cells
HIV/AIDS Coinfection - Hepatitis B treatment for HIV patients reviewed
Heat Shock Proteins - Neuroprotection due to HSP induction may occur with geranylgeranylacetone
Hepatitis A Virus - No further cases reported in Pennsylvania outbreak
Hepatitis B Virus - Chimeric antibodies target hepatitis B virus pre-S2 surface antigen
Hepatitis C Therapy - Data reported from phase IB trial of Isatoribine
Transgenics - Rodents with inducible suicide genes will advance liver disease drug research
Hepatitis C Virus - Investigational drug, merimepodib, well tolerated in hepatitis C clinical trial
Hepatitis Virus - Biotechnology company increases production capacity of liver treatment
Hepatitis Virus - Interim findings reported on Infergen plus Actimmune combination therapy
Hepatology - Hepatitis C virus in tissue samples helps identify mixed up patient specimens
Immunoglobulin Therapy - The combination of high serum albumin, fibrinogen, Ig may pose a thrombotic risk
Initial Public Offering - Pharmaceutical company files registration statement for proposed IPO
Kidney Transplant - Acute kidney rejection is lower with basiliximab, independent of cyclosporine
Liver Cancer - Aflatoxin B-1 and hepatitis B virus synergize to encourage hepatocarcinogenesis
Liver Cancer - Liver cells that encode for HCRP1 avoid hepatocellular carcinoma
Mutagenesis - Murine models of human liver cancer exemplify malignant mechanisms
Immunology - Hepatitis C and Schistosoma mansoni coinfections cause T-cell depletion
Oncology - Chemoembolization improves survival for many with unresectable liver cancer
Pain Medicine - Desflurane general anesthesia alters hepatic venous pressure
Transplant Medicine - Renal function improves in pediatric liver transplant by switch in monitoring
Viral Proteomics - Hepatitis C virus core protein upregulates TGF-beta1 transcription
Virology - A new line probe assay identifies hepatitis B virus precore variants in sera
Virology - Alpha-actinin may be essential for hepatitis C virus replication
Neuropathy - Hepatitis C virus infection may encourage the formation of diabetic amyotrophy
Virology - Response to hepatitis C virus therapy can be predicted within 4 weeks
Adverse Drug Effects - Liver transplant patients with renal dysfunction from CNI may improve with MMF
Biliary Cirrhosis - Primary biliary cirrhosis research at Mount Sinai advances due to trust, trials
Blood Transfusion - Blood sterility testing must be from a bag location that avoids false positivity
Chronic Hepatitis C - Non-obligate chain-terminating ribonucleoside analogs inhibit HCV replication
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.